Lombard Odier Asset Management (USA) Corp 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-09 1:16 pm Sale | 2025-12-31 | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 5,935,955 4.200% | -4,777,672 (-44.59%) | Filing |
| 2025-02-11 6:41 pm Purchase | 2024-12-31 | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 10,713,627 7.600% | 2,721,396 (+34.05%) | Filing |
| 2024-11-14 1:13 pm Sale | 2024-09-30 | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 7,992,231 5.700% | -3,645,288 (-31.32%) | Filing |
| 2024-02-14 09:54 am Purchase | 2023-12-31 | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 11,637,519 10.400% | 10,317 (+0.09%) | Filing |
| 2023-02-14 10:45 am Purchase | 2022-12-31 | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 11,627,202 10.800% | 1,209,639 (+11.61%) | Filing |
| 2022-02-10 4:44 pm Sale | 2021-12-31 | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 10,417,563 11.600% | -503,008 (-4.61%) | Filing |